Arecoline Tripeptide Inhibitors of Proteasome

Journal of Medicinal Chemistry

Volumn 47, Issue 6, 2004, Pages 1587-1590

  Marastoni, Mauro ^a   Baldisserotto, Anna ^a   Canella, Alessandro ^a   Gavioli, Riccardo ^a   De Risi, Carmela ^a   Pollini, Gian Piero ^a   Tomatis, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARECOLINE; PROTEASOME INHIBITOR; TRIPEPTIDE;

ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL MEMBRANE PERMEABILITY; CYTOTOXIC T LYMPHOCYTE; DERIVATIZATION; ENZYME INHIBITION; HYDROPHOBICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE ANALYSIS; PROTEIN DEGRADATION;

ARECOLINE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DRUG STABILITY; ENZYME INHIBITORS; HUMANS; MULTIENZYME COMPLEXES; OLIGOPEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 1542328049     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0309102     Document Type: Article

References (21)

1. Ciechanover, A. The ubiquitin-proteasome proteolytic pathway. Cell 1994, 79, 13-21.
2. Coux, O.; Tanaka, K.; Golberg, A. L. Structure and function of the 20S and 26S proteasomes. Annu. Rev. Biochem. 1996, 65, 801-847.
3. Matthews, W.; Dricoll, J.; Tanaka, K.; Ichihara, A.; Golberg, A. L. Involvment of the proteasome in various degradative processes in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 2597-2601.
4. Tanaka, K.; Tanahashi, N.; Tsurumi, C.; Yokata, K. Y.; Shimbara, N. Proteasomes and antigen processing. Adv. Immunol. 1997, 64, 1-38.
5. Rock, K. L.; Golberg, A. L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 1999, 17, 739-779.
6. Orlowski, R. Z. The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ. 1999, 6, 303-313.
7. Kisselev, A. F.; Golberg, A. L. Proteasome inhibitors: from research tools to drugs candidates. Chem. Biol. 2001, 8, 739-758.
8. Iqbal, M.; Chatterjee, S.; Kauer, J. C.; Das, M.; Messina, P. A.; Freed, B.; Biazzo, W.; Siman, R. Potent inhibitors of proteasome. J. Med. Chem. 1995, 38, 2276-2277.
9. Iqbal, M.; Chatterjee, S.; Kauer, J. C.; Mallamo, J. P.; Messina, P. A.; Reiboldt, A.; Siman, R. Potent a-ketocarbonil and boronic ester derived inhibitors of proteasome. Bioorg. Med. Chem. Lett. 1996, 6, 287-290.
10. Bogyo, M.; McMaster, J. S.; Gaczynska, M.; Tortorella, D.; Goldberg, A. L.; Ploegh, H. Covalent modification of the active site Thr of proteasome beta-subunits and the E. coli homologue HslV by a new class of inhibitors. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 6629-6634.
11. Craiu, A.; Gaczynska, M.; Akopian, T.; Gramm, C. F.; Fenteany, G.; Golberg, A. L.; Rock, K. L. Lactacystin and clasto-lactacystin -lactone modify multiple proteasome -subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 1997, 272, 13437-13445.
12. Meng, L.; Mohan, R.; Kwok, B. H.; Elofsson, M.; Sin, N.; Crews, C. M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antinflammatory activity. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 10403-10408.
13. Loidl, G.; Groll, M.; Musiol, H. J.; Ditzel, L.; Huber, R.; Moroder, L. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes. Chemistry & Biology. 1999, 6, 197-203.
14. Chatterjee, S.; Dunn, D.; Mallya, S.; Ator, M. A. P′-extended α-ketoamide inhibitors of proteasome. Bioorg. Med. Chem. Lett. 1999, 9, 2603-2606.
15. Olofson, R. A.; Martz, J. T.; Senet, J.-P.; Piteau, M.; Malfroot, T. A. New reagent for the selective, high-yield N-dealkylation of tertiary amines: improved syntheses of naltrexone and nalbuphine. J. Org. Chem. 1984. 49, 2081-2082.
16. Jakobsen, P.; Lundbeck, J. M.; Kristiansen, M.; Breinholt, J.; Demuth, H.; Pawlas, J.; Torres Candela, M. P.; Andersen, B.; Westergaard, N.; Lundgren, K.; Asano, N. Iminosugar: potential inhibitor of liver glycigen phosphorylase. Bioorg. Med. Chem. 2001, 9, 733-744.
17. Hendil, K. B.; Uerkvitz, W. The human multicatalytic proteinase: affinity purification using a monoclonal antibody. J. Biochem. Biophys. Methods. 1991, 22, 159-165.
18. Elofsson, M.; Splittgerber, U.; Myung, J.; Mohan, R.; M Crews, C. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide α′,β′-epoxyketones. Chem. Biol. 1999, 6, 811-822.
19. Groll, M.; Nazif, T.; Huber, R.; Bogyo, M. Probing structural determinants distal to the site of hydrolysis that control substrate specificity of the 20S proteasome. Biol. Chem. 2002, 9, 655-662.
20. Gavioli, R.; Vertuani, S.; Masucci, M. G. Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors. Int. J. Cancer 2002, 101, 532-538.
21. 1-dimethylaminopropyl)carbodiimide; Z, benzyloxycarbonyl.